Announcements Trials
Browse Landscape

Phase

Phase 2 24Phase NA 11Phase 3 5Phase 1/2 5Phase 1 4Phase EARLY_PHASE1 1Phase 2/3 1

Status

Recruiting 5Not yet recruiting 2Completed 2Unknown 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Lymphoid 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 129Carcinoma, Non-Small-Cell Lung 101Prostatic Neoplasms 62Colorectal Neoplasms 49Nasopharyngeal Carcinoma 46Neoplasms 43Multiple Myeloma 41Stomach Neoplasms 34Lung Neoplasms 32Ovarian Neoplasms 31Neoplasm Metastasis 31Leukemia, Myeloid, Acute 31Carcinoma, Hepatocellular 29Squamous Cell Carcinoma of Head and Neck 27Rectal Neoplasms 27Triple Negative Breast Neoplasms 25Recurrence 25Pancreatic Neoplasms 25Small Cell Lung Carcinoma 21Esophageal Neoplasms 21Brain Neoplasms 21Uterine Cervical Neoplasms 20Colonic Neoplasms 20Lymphoma, Large B-Cell, Diffuse 18Head and Neck Neoplasms 17Urinary Bladder Neoplasms 16Leukemia, Lymphocytic, Chronic, B-Cell 16Esophageal Squamous Cell Carcinoma 16Carcinoma, Renal Cell 16Myasthenia Gravis 15

Interventions

obinutuzumab 1fludarabine 1Radiotherapy 1Mitoxantrone 1Gemtuzumab 1Folfox protocol 1Daunorubicin 1Cytarabine 1Cyclophosphamide 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × Neoplasm, Residual × Clear all
NCT05232916 2026-03-19

FLAMINGO-01

Greenwich LifeSciences, Inc.

Phase 3 Recruiting
750 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT07441291 2026-02-27

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Peking University People's Hospital

Phase 3 Recruiting
70 enrolled
Tumor-Agnostic

Neoplasm, Residual

NCT05929222 2025-12-24

FIL_GAZEBO

Fondazione Italiana Linfomi - ETS

Phase 3 Recruiting
190 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT05534087 2024-11-29

CLAUDIA

Seoul National University Hospital

Phase 3 Recruiting
236 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasm, Residual

NCT02724163 2021-10-08

Myechild01

University of Birmingham

Phase 3 Recruiting
700 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡